These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33704597)

  • 1. Clinical Implications of the ISCHEMIA Trial: Invasive vs Conservative Approach in Stable Coronary Disease.
    Choudhary J; Chiu S; Bhugra P; Bikdeli B; Supariwala A; Jauhar R; Chatterjee S
    Curr Cardiol Rep; 2021 Mar; 23(5):43. PubMed ID: 33704597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. After ISCHEMIA: Is cardiac MRI a reliable gatekeeper for invasive angiography and myocardial revascularization?
    Nagel E; Carerj ML; Arendt CT; Puntmann VO
    Herz; 2020 Aug; 45(5):446-452. PubMed ID: 32458013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate therapy for patients with stable ischemic heart disease: a review of literature and the implication of the International Study of Comparative Effectiveness with Medical and Invasive Approaches trial.
    Guo MH; Nantsios A; Ruel M
    Curr Opin Cardiol; 2020 Nov; 35(6):658-663. PubMed ID: 32941193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
    Cheng-Torres KA; Desai KP; Sidhu MS; Maron DJ; Boden WE
    Future Cardiol; 2016 Jan; 12(1):35-44. PubMed ID: 26696561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.
    Bangalore S; Maron DJ; Fleg JL; O'Brien SM; Herzog CA; Stone GW; Mark DB; Spertus JA; Alexander KP; Sidhu MS; Chertow GM; Boden WE; Hochman JS;
    Am Heart J; 2018 Nov; 205():42-52. PubMed ID: 30172098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
    Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Alexander KP; Senior R; Boden WE; Stone GW; Goodman SG; Lopes RD; Lopez-Sendon J; White HD; Maggioni AP; Shaw LJ; Min JK; Picard MH; Berman DS; Chaitman BR; Mark DB; Spertus JA; Cyr DD; Bhargava B; Ruzyllo W; Wander GS; Chernyavskiy AM; Rosenberg YD; Maron DJ;
    JAMA Cardiol; 2019 Mar; 4(3):273-286. PubMed ID: 30810700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature.
    Songco AV; Brener SJ
    Curr Cardiol Rep; 2012 Aug; 14(4):397-407. PubMed ID: 22555943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    Maron DJ; Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Boden WE; Chaitman BR; Senior R; López-Sendón J; Alexander KP; Lopes RD; Shaw LJ; Berger JS; Newman JD; Sidhu MS; Goodman SG; Ruzyllo W; Gosselin G; Maggioni AP; White HD; Bhargava B; Min JK; Mancini GBJ; Berman DS; Picard MH; Kwong RY; Ali ZA; Mark DB; Spertus JA; Krishnan MN; Elghamaz A; Moorthy N; Hueb WA; Demkow M; Mavromatis K; Bockeria O; Peteiro J; Miller TD; Szwed H; Doerr R; Keltai M; Selvanayagam JB; Steg PG; Held C; Kohsaka S; Mavromichalis S; Kirby R; Jeffries NO; Harrell FE; Rockhold FW; Broderick S; Ferguson TB; Williams DO; Harrington RA; Stone GW; Rosenberg Y;
    N Engl J Med; 2020 Apr; 382(15):1395-1407. PubMed ID: 32227755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial.
    White HD; O'Brien SM; Alexander KP; Boden WE; Bangalore S; Li J; Manjunath CN; Lopez-Sendon JL; Peteiro J; Gosselin G; Berger JS; Maggioni AP; Reynolds HR; Hochman JS; Maron DJ
    JAMA Cardiol; 2021 Sep; 6(9):1023-1031. PubMed ID: 33938917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical revascularization for stable coronary syndrome: the ISCHEMIA trial versus a single-centre matched population-a real-world analysis of patients undergoing surgical revascularization.
    De Martino A; Del Re F; Gregori D; Azzolina D; Pascarella C; Falcetta G; Ravenni G; Celiento M; Morganti R; Colli A
    Eur J Cardiothorac Surg; 2022 May; 61(5):1155-1161. PubMed ID: 35143617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease.
    Vafaei P; Naderi S; Ambrosy AP; Slade JJ
    Curr Atheroscler Rep; 2021 Sep; 23(11):70. PubMed ID: 34468881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    Stone GW; Hochman JS; Williams DO; Boden WE; Ferguson TB; Harrington RA; Maron DJ
    J Am Coll Cardiol; 2016 Jan; 67(1):81-99. PubMed ID: 26616030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial Ischemia in the Management of Chronic Coronary Artery Disease: Past and Present.
    Gibbons RJ
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011615. PubMed ID: 33455408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications and Debates on the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches Trial.
    Saito Y; Nishi T; Saito K; Kitahara H; Kawase Y; Matsuo H; Kobayashi Y
    Cardiol Rev; 2022 Sep-Oct 01; 30(5):234-240. PubMed ID: 33758121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center.
    Wasilewski J; Poloński L; Lekston A; Osadnik T; Reguła R; Bujak K; Kurek A
    Trials; 2015 Sep; 16():411. PubMed ID: 26373291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term clinical outcomes between revascularization versus medical treatment in patients with silent myocardial ischemia.
    Choi KH; Lee JM; Park I; Kim J; Rhee TM; Hwang D; Park J; Park TK; Yang JH; Song YB; Hahn JY; Jeong DS; Cho YH; Kim WS; Sung K; Jang MJ; Sung JD; Choi JH; Choi SH; Koo BK; Lee YT; Kim EK; Chang SA; Park SJ; Choi JO; Lee SC; Park SW; Cho YS; Choi JY; Gwon HC; Oh JK
    Int J Cardiol; 2019 Feb; 277():47-53. PubMed ID: 30093138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ISCHEMIA in stable ischemic heart disease.
    Spilias N; Zorach B; Denby K; Ellis S
    Cleve Clin J Med; 2020 Jun; 87(7):401-409. PubMed ID: 32636193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.